Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes

Leukemia Research

Volumn 36, Issue 7, 2012, Pages

  Kim, In Ho ^a   Youn, Jae Ho ^a   Shin, Seung Hwan ^a   Yahng, Seung Ah ^a   Lee, Sung Eun ^a   Kwon, Jae Cheol ^a   Lee, Dong Gun ^a   Park, Kyung Shin ^a   Choi, Moon Hyung ^a   Jung, Seung Eun ^a   Kim, Yoo Jin ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; C REACTIVE PROTEIN; CORTICOSTEROID; HYDROXYCHLOROQUINE; INSULIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRUG FEVER; FEMALE; FEVER; HUMAN; HUMAN TISSUE; INJECTION SITE ERYTHEMA; KARYOTYPE; LETTER; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPHILIC PANNICULITIS; PANNICULITIS; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SKIN BIOPSY; SKIN NODULE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHIL INFILTRATION; PANNICULITIS;

EID: 84862339721     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.03.007     Document Type: Letter

References (10)

1. Fenaux P., Mufti G.J., Hellstrom-Lindberg E., Santini V., Finelli C., Giagounidis A., et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009, 10:223-232.
2. Santini V., Fenaux P., Mufti G.J., Hellström-Lindberg E., Silverman L.R., List A., et al. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine. Eur J Haematol 2010, 85:130-138.
3. Alencar C., Abramowtiz M., Parekh S., Braunshweig I., Jacobson M., Silverman L., et al. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol 2009, 84:688-689.
4. Becherer K., Golda N., Feldman M., Diaz-Arias A., Caldwell C. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms. J Cutan Pathol 2009, 36:1024-1026.
5. Assouline S., Laneuville P., Gambacorti-Passerini C. Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia. N Engl J Med 2006, 354:2623-2624.
6. Schwartz R.A., Nervi S.J. Erythema nodosum: a sign of systemic disease. Am Fam Physician 2007, 75:695-700.
7. Ramdial P.K., Naidoo D.K. Drug-induced cutaneous pathology. J Clin Pathol 2009, 62:493-504.
8. Morrison L.K., Rapini R., Willison C.B., Tyring S. Infection and panniculitis. Dermatol Ther 2010, 23:328-340.
9. Matsumura Y., Tanabe H., Wada Y., Ohta K., Okamoto H., Imamura S. Neutrophilic panniculitis associated with myelodysplastic syndromes. Br J Dermatol 1997, 136:142-144.
10. Chen H.C., Kao W.Y., Chang D.M., Gao H.W., Lai W.Y., Lai J.H. Neutrophilic panniculitis with myelodysplastic syndromes presenting as pustulosis: case report and review of literature. Am J Hematol 2004, 76:61-65.